Health Made Accessbile
A new business model to increase access to innovation in health
Focused on developing new products for neglected health issues
- Traditional company models are currently not sufficient in addressing global access challenges for underserved communities.
- The predominant central lab model for diagnostics is not optimal for the global south applications.
- Expanding diagnostics tests that are accessible and affordable have become key in addressing recent pandemic needs.
Where do we fit among these models?
GAH’s model, as a capped-profit, social enterprise, combines the best of both of these models. It means that we invest in financially sustainable companies but our primary goal is impact. All profits generated are re-invested back in our mission to increase access to innovation in health.
Our vision is to expand access to affordable, high quality diagnostics and medical solutions to underserved communities in the Global South, through decentralized research, development, and manufacturing.
Our focus will be on expanding community access beyond the clinical care setting, starting with diagnostics but eventually moving into other adjacencies (e.g., portable devices, digital solutions).
Our Approach
GAH is a unique membership organisation, where investors become stakeholders in a social enterprise. This means we do not have shareholders or other investors who are looking for a commercial return or a possible exit in a defined time horizon.
The members are committed to making investments in great organisations that can bring innovations for neglected health challenges to market in a sustainable and equitable manner. Learn more about our first portfolio company, Global Access Diagnostics or learn more about how to partner with us
